Detailing formulation approaches by stage of discovery to early development, this book gives a “playbook” of practical and efficient strategies to formulate drug candidates with the least chance of failing in clinical development.
• Comes from contributing authors with experience developing formulations on the frontlines of the pharmaceutical industry
• Focuses on pre (or non-) clinical and early stage development, the phases where most compounds are used in drug research
• Features case studies to illustrate practical challenges and solutions in formulation selection
• Covers regulatory filing, drug metabolism and physical and chemical properties, toxicology formulation, biopharmaceutics classification system (BCS), screening approaches, early stage clinical formulation development, and outsourcing
